Skip to content

Released Apr 13, 2018, after the close

10-Q filed May 15, 2018, 45 days after period end · 0001390478-18-000010

Q1 2018 · 10-Q
Revenue—
Net Income-$8.00MN/M vs Q1 2017N/M vs Q4 2017
EPS Diluted-$1.67N/M vs Q1 2017no prior Q4 2017 on file
Operating Cash Flow-$5,403,000N/M

What the release said

The release

Same quarter

MetricQ1 2018Q1 2017Q1 2016Q1 2015
Revenue———$2.75M
Net Income-$8.00M-$4.60M-$16.49M-$10.54M
EPS Diluted-$1.67-$3.63—-$0.08

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR